|
ASHP Survey Reveals Pharmacists’ Role in Substance Abuse Care
|
|
What does the future look like for pharmacy practice? A new survey from the American Society of Health-System Pharmacists (ASHP) attempted to answer that question, focusing on adolescent substance use disorders, government investment in programs to reduce health disparities, and the influence of ultra-high–cost drugs on services provided by hospitals. Read more.
|
|
|
Home Test to Treat Program Expands From Original Pilot
|
|
|
Many pharmacies have been part of government-sponsored test-to-treat programs for COVID-19. Now, those programs are being expanded to home-based care and will also include testing and treatment for influenza. Find out what the changes will mean, which patients are eligible, and how pharmacies will still be involved.
|
|
Factors That Predict Likely BC Drug Discontinuation
|
|
|
A combination of factors, including unpleasant side effects and cost, cause women with breast cancer (BC) to discontinue aromatase inhibitor therapy earlier than they should. A study presented at the 2023 San Antonio Breast Cancer Symposium proposes a way to predict which patients are most likely to have problems with adherence to the drugs and how interventions can be tailored to them. Read more.
|
|
|
Bimekizumab Shows Promise in Treating Palmoplantar Pustular Psoriasis
|
|
Palmoplantar pustulosis and palmoplantar plaque psoriasis with pustules profoundly affect patient quality of life and are notoriously challenging to treat. A new drug recently approved for the treatment of moderate-to-severe plaque psoriasis in adults is showing some promise in the other difficult conditions. Find out how effective bimekizumab was in a small study in France.
|
|
